RGC — Regencell Bioscience Holdings Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapNeutral

Annual balance sheet for Regencell Bioscience Holdings, fiscal year end - June 30th, USD millions except per share, conversion factor applied.

	2019 June 30th	2020 June 30th	2021 June 30th	2022 June 30th	2023 June 30th
Period Length:	—	—	—	—	—
Source:	PROSPECTUS/A	PROSPECTUS/A	20-F	20-F	20-F
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Short Term Investments
Cash and Short Term Investments	0.243	0.387	0.059	16.4	11.6
Prepaid Expenses
Total Current Assets	0.243	0.387	0.067	16.4	11.6
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0	0.108	0.082	1.46	0.892
Other Long Term Assets
Total Assets	0.243	0.514	0.34	18	12.6
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	2.08	3.16	4.34	0.578	0.607
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Liabilities	2.08	3.16	4.34	0.953	0.591
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	-1.84	-2.65	-4	17.1	12
Total Liabilities & Shareholders' Equity	0.243	0.514	0.34	18	12.6
Total Common Shares Outstanding